Medisinsk forskning på cannabis
I dette arkivet finner du over 15 000 lenker til forskningsartikler og studier på cannabis planten. Listen er på engelsk, delt opp i medisinske lidelser og andre kategorier i alfabetisk rekkefølge.
NB! Sidene på hver bokstav kan laste tregt da tusenvis av linker lastes
B
BACK PAIN (7)
-
Investigational pharmacology for low back pain
-
Cannabinoids and muscular pain. Effectiveness of the local administration in rat
-
Pot a Common Remedy to Ease Back Pain
-
Monterey County seniors finding pain relief in medical marijuana
-
DR ALLAN FRANKELâS EARLY VERSION INITIAL DOSAGE AND ADMINISTRATION GUIDE
-
When Weed Is The Cure: A Doctorâs Case for Medical Marijuana
-
How can medical marijuana help with â¦. BACK PAIN?
BILE/BILE DUCTS (12)
-
Cannabidiol ameliorates cognitive and motor impairments in bile-duct ligated mice via 5- HT1A receptor activation
-
G1359A polymorphism of the cannabinoid receptor gene (CNR1) and clinical results of biliopancreatic diversion
-
Distribution of free and conjugated cannabinoids in human bile samples
-
Role of cannabinoid receptors in hepatic fibrosis and apoptosis associated with bile duct ligation in rats
-
Gut microbiota and obesity: Role in aetiology and potential therapeutic target
-
Bile salt recognition by human liver fatty acid binding protein
-
Orphan nuclear receptor oestrogen-related receptor γ (ERRγ) plays a key role in hepatic cannabinoid receptor type 1-mediated induction of CYP7A1 gene expression
-
Fatty acid binding protein 5 (FABP5) regulates diet-induced obesity (DIO) via GIP secretion from enteroendocrine K-cells in response to fat ingestion
-
Fasiglifam (TAK-875) Inhibits Hepatobiliary Transporters: A Possible Factor Contributing to Fasiglifam-Induced Liver Injury
-
Role of Gut Microbiota in the Aetiology of Obesity: Proposed Mechanisms and Review of the Literature
-
Bile Acid Recognition by NAPE-PLD
-
Distribution of Synthetic cannabinoids JWH-210, RCS-4 and â 9-Tetrahydrocannabinol After Intravenous Administration to Pigs
BIMODAL/PARADOXICAL EFFECTS (24)
-
Paradoxical effects of the cannabinoid CB2 receptor agonist GW405833 on rat osteoarthritic knee joint pain
-
Cannabinoid-Induced Hyperemesis: A ConundrumâFrom Clinical Recognition to Basic Science Mechanisms
-
Bimodal control of stimulated food intake by the endocannabinoid systemÂ
-
The dual effects of delta(9)-tetrahydrocannabinol on cholangiocarcinoma cells: antiinvasion activity at low concentration and apoptosis induction at high concentration.
-
Biphasic Effects of Cannabinoids in Anxiety Responses: CB1 and GABA(B) Receptors in the Balance of GABAergic and Glutamatergic Neurotransmission
-
The cannabinoid CB1 receptor biphasically modulates motor activity and regulates dopamine and glutamate release region dependently
-
Bimodal Control of Fear-Coping Strategies by CB1 Cannabinoid ReceptorsÂ
-
Biphasic effects of Î9-tetrahydrocannabinol on brain stimulation reward and motor activity
-
Cannabinoid hyperemesis syndrome: Marijuana is both antiemetic and proemeticÂ
-
Alcohol Versus Cannabinoids: A Review of Their Opposite Neuro-Immunomodulatory Effects and Future Therapeutic Potentials
-
Cannabinoid Hyperemesis Syndrome: A Paradoxical Cannabis Effect
-
Current Status and Future of Cannabis Research
-
Palmitoylethanolamide attenuates PTZ-induced seizures through CB1 and CB2 receptors
-
Biphasic effects of anandamide on behavioural responses: emphasis on copulatory behaviour.
-
Endogenous and Synthetic Cannabinoids as Therapeutics in Retinal Disease
-
Behavioral Characterization of the Effects of Cannabis Smoke and Anandamide in Rats
-
Tolerance to the diuretic effects of cannabinoids and cross-tolerance to a kappa-opioid agonist in THC-treated mice
-
The Cannabinoid CB1/CB2 Agonist WIN55212.2 Promotes Oligodendrocyte Differentiation In Vitro and Neuroprotection During the Cuprizone-Induced Central Nervous System Demyelination
-
Bidirectional Effects of Cannabidiol on Contextual Fear Memory Extinction
-
A userâs guide to cannabinoid therapies in oncology
-
Concentration, population, and context-dependent effects of AM251 in zebrafish
-
Intra-VTA anandamide infusion produces dose-based biphasic effects on male rat sexual behavior expression
-
Endocannabinoid system in sexual motivational processes: is it a novel therapeutic horizon?
-
Regulation of cannabinoid CB2 receptor constitutive activity in vivo: repeated treatments with inverse agonists reverse the acute activation of JNK and associated apoptotic signaling in mouse brain
BIPOLAR DISORDER (16)
-
Genetic association between bipolar disorder and 524A>C (Leu133Ile) polymorphism of CNR2 gene, encoding for CB2 cannabinoid receptor
-
Cognitive and clinical outcomes associated with cannabis use in patients with bipolar I disorder
-
No association of endocannabinoid genes with bipolar disorder or lithium response in a Sardinian sample
-
Is there a role for palmitoylethanolamide in the treatment of depression?
-
Cannabis for Bipolar
-
The association between cannabis use and mood disorders: A longitudinal study
-
Endocannabinoids and Mental Disorders
-
Joint Effects: A Pilot Investigation of the Impact of Bipolar Disorder and Marijuana Use on Cognitive Function and Mood.
-
Endocannabinoid signaling in social functioning: an RDoC perspective
-
Lipids in psychiatric disorders and preventive medicine
-
Gender Differences in Associations Between Attention-Deficit/Hyperactivity Disorder and Substance Use Disorder
-
Cognitive Function in Individuals With Psychosis: Moderation by Adolescent Cannabis Use
-
Cannabinoid hyperemesis syndrome and the onset of a manic episode
-
The Effects of Cannabis on Inpatient Agitation, Aggression, and Length of Stay
-
Pros and cons of medical cannabis use by people with chronic brain disorders
-
Brain circuitry associated with the development of substance use in bipolar disorder and preliminary evidence for sexual dimorphism in adolescents
BLADDER/URINARY FUNCTIONS (47)
-
Effects of cannabinor, a novel selective cannabinoid 2 receptor agonist, on bladder function in normal rats
-
Randomized controlled trial of Sativex to treat detrusor overactivity in multiple sclerosis
-
Transient receptor potential A1 and cannabinoid receptor activity in human normal and hyperplastic prostate: relation to nerves and interstitial cells
-
Cannabinor, a selective cannabinoid-2 receptor agonist, improves bladder emptying in rats with partial urethral obstruction
-
Effects of cannabinor, a novel selective cannabinoid 2 receptor agonist, on bladder function in normal rats
-
Randomized controlled trial of Sativex to treat detrusor overactivity in multiple sclerosis
-
Local activation of cannabinoid CB1 receptors in the urinary bladder reduces the inflammation-induced sensitization of bladder afferents
-
Modulation of inflammatory responses by a cannabinoid-2-selective agonist after spinal cord injury
-
Inhibitory Effect of Standardized Cannabis sativa Extract and Its Ingredient Cannabidiol on Rat and Human Bladder Contractility
-
Cannabinoids: potential targets for bladder dysfunction
-
Cannabinoid mediated diuresis in mice
-
Spinal Cord Fatty Acid Amide Hydrolase (FAAH) in Normal Micturition Control and Bladder Overactivity in Awake Rats
-
Expression of fatty acid amide hydrolase (FAAH) in human, mouse, and rat urinary bladder and effects of FAAH inhibition on bladder function in awake rats
-
Nabiximols in the treatment of spasticity, pain and urinary symptoms due to multiple sclerosis
-
Distribution and function of the endocannabinoid system in the rat and human bladder
-
Cannabinoids and the endocannabinoid system in lower urinary tract function and dysfunction
-
Diuretic effects of cannabinoids
-
Bladder function in a cannabinoid receptor type 1 knock-out mouse
-
Characterization of bladder function in a cannabinoid receptor type 2 knockout mouse in vivo and in vitro
-
Diuretic effects of cannabinoid agonists in mice
-
Nephrogenic adenoma of the urinary tract: clinical, histological, and immunohistochemical characteristics
-
Systematic review: Efficacy and safety of medical marijuana in selected neurologic disorders: Report of the Guideline Development Subcommittee of the American Academy of Neurology
-
Current and future drugs for treatment of MS-associated bladder dysfunction
-
Inhibition of Peripheral Fatty Acid Amide Hydrolase Depresses Activities of Bladder Mechanosensitive Nerve Fibers of the Rat
-
Evaluation of the tolerability and efficacy of Sativex in multiple sclerosis
-
Attenuation of Cystitis and Pain Sensation in Mice Lacking Fatty Acid Amide Hydrolase
-
Complementary and alternative medical therapies in multiple sclerosis-the american academy of neurology guidelines: a commentary
-
Intrathecal cannabinoid-1 receptor agonist prevents referred hyperalgesia in acute acrolein-induced cystitis in rats
-
The entourage effect: Synergistic actions of plant cannabinoids
-
Activation of cannabinoid receptor 1 inhibits increased bladder activity induced by nerve growth factor
-
Spinal neuronal cannabinoid receptors mediate urodynamic effects of systemic fatty acid amide hydrolase (FAAH) inhibition in rats
-
URB937, a peripherally-restricted inhibitor for fatty acid amide hydrolase, reduces prostaglandin E2 -induced bladder overactivity and hyperactivity of bladder mechano afferent nerve fibers in rats
-
Effect of Non-psychotropic Plant-derived Cannabinoids on Bladder Contractility: Focus on Cannabigerol
-
Cannabinoid receptor expression in the bladder is altered in detrusor overactivity
-
The role of the peripheral cannabinoid system in the pathogenesis of detrusor overactivity evoked by increased intravesical osmolarity in rats
-
Can Medical Marijuana Treat Multiple Sclerosis?
-
Endocannabinoids and the Digestive Tract and Bladder in Health and Disease
-
New therapeutic strategies for the treatment of male lower urinary tract symptoms
-
Tolerance to the diuretic effects of cannabinoids and cross-tolerance to a kappa-opioid agonist in THC-treated mice
-
Unmasking roles of the peripheral endocannabinoid system associated with bladder overactivity
-
Impaired Excitatory Neurotransmission in the Urinary Bladder from the Obese Zucker Rat: Role of Cannabinoid Receptors
-
Effects of cannabinoid receptor activation by CP55,940 on normal bladder function and irritation-induced bladder overactivity in non-awake anaesthetised rats
-
Anandamide transporter-mediated regulation of the micturition reflex in urethaneanesthetized rats
-
The endocannabinoid system â a target for the treatment of LUTS?
-
Treatment of Bladder Dysfunction
-
Role of Cannabinoid Receptor Type 1 in Tibial and Pudendal Neuromodulation of Bladder Overactivity in Cats
-
Cannabinoids for treating neurogenic lower urinary tract dysfunction in patients with multiple sclerosis: a systematic review and meta-analysis
BLISTERS/BLISTERING (1)
BLOOD-BRAIN BARRIER/BLOOD-SPINAL CORD BARRIER (52)
-
Interaction of drugs of abuse and maintenance treatments with human P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2)
-
Anandamide suppresses pain initiation through a peripheral endocannabinoid mechanism
-
Anandamide inhibits Theilerâs virus induced VCAM-1 in brain endothelial cells and reduces leukocyte transmigration in a model of blood brain barrier by activation of CB1 receptors
-
Honokiol crosses BBB and BCSFB, and inhibits brain tumor growth in rat 9L intracerebral gliosarcoma model and human U251 xenograft glioma model
-
HIV-1 infection and alcohol abuse: neurocognitive impairment, mechanisms of neurodegeneration and therapeutic interventions
-
Activation of cannabinoid receptor 2 attenuates leukocyte-endothelial cell interactions and blood-brain barrier dysfunction under inflammatory conditions
-
Mast cell-glia axis in neuroinflammation and therapeutic potential of the anandamide congener palmitoylethanolamide
-
Targeting the endocannabinoid system with cannabinoid receptor agonists: pharmacological strategies and therapeutic possibilities
-
A cannabinoid type 2 receptor agonist attenuates blood-brain barrier damage and neurodegeneration in a murine model of traumatic brain injury
-
Effects of cannabinoid receptor agonist WIN 55,212-2 on blood-brain barrier disruption in focal cerebral ischemia in rats
-
Selective inhibition of alpha/beta-hydrolase domain 6 attenuates neurodegeneration, alleviates blood brain barrier breakdown, and improves functional recovery in a mouse model of traumatic brain injury
-
Multiple sclerosis and the blood-central nervous system barrier
-
Cannabidiol provides long-lasting protection against the deleterious effects of inflammation in a viral model of multiple sclerosis: A role for A2A receptors
-
Selective Activation of Cannabinoid Receptor 2 in Leukocytes Suppresses Their Engagement of the Brain Endothelium and Protects the Blood-Brain Barrier
-
Role of the cannabinoid system in the transit of beta-amyloid across the blood-brain barrier
-
The Endocannabinoid Anandamide Mediates Hypoxic Pulmonary Vasoconstriction And Pulmonary Hypertension
-
CB2 Receptor Activation Inhibits Melanoma Cell Transmigration through the Blood-Brain Barrier
-
Cannabinoids: well-suited candidates for the treatment of perinatal brain injury
-
Cannabinoid type 2 receptor stimulation attenuates brain edema by reducing cerebral leukocyte infiltration following subarachnoid hemorrhage in rats
-
Roles of fatty acid ethanolamides (FAE) in traumatic and ischemic brain injury
-
Functions of the CB1 and CB 2 Receptors in Neuroprotection at the Level of the Blood-Brain Barrier
-
Cannabinoid receptor CB2 is expressed on vascular cells, but not astroglial cells in the post-mortem human Huntingtonâs disease brain
-
Cannabinoid Receptor-2 and HIV-Associated Neurocognitive Disorders
-
Endocannabinoid degradation inhibition improves neurobehavioral function, blood brain barrier integrity, and neuroinflammation following mild traumatic brain injury
-
Roles of fatty acid ethanolamides (FAE) in traumatic and ischemic brain injury
-
Functions of the CB1 and CB 2 Receptors in Neuroprotection at the Level of the Blood Brain Barrier
-
Cannabinoid receptor CB2 is expressed on vascular cells, but not astroglial cells in the post-mortem human Huntingtonâs disease brain
-
Cannabinoid Receptor-2 and HIV-Associated Neurocognitive Disorders
-
4â²-O-methylhonokiol increases levels of 2-arachidonoyl glycerol in mouse brain via selective inhibition of its COX-2-mediated oxygenation
-
Changes in cannabinoid receptors, aquaporin 4 and vimentin expression after traumatic brain injury in adolescent male mice. Association with edema and neurological deficit
-
Endocannabinoids modulate human blood-brain barrier permeability in vitro
-
Activation of Cannabinoid Type Two Receptors (CB2) Diminish Inflammatory Responses in Macrophages and Brain Endothelium
-
Cannabinoid Signaling and Neuroinflammatory Diseases: A Melting pot for the Regulation of Brain Immune Responses
-
4â²-O-methylhonokiol increases levels of 2-arachidonoyl glycerol in mouse brain via selective inhibition of its COX-2-mediated oxygenation
-
Changes in cannabinoid receptors, aquaporin 4 and vimentin expression after traumatic brain injury in adolescent male mice. Association with edema and neurological deficitÂ
-
Activation of Cannabinoid Type Two Receptors (CB2) Diminish Inflammatory Responses in Macrophages and Brain Endothelium
-
Endocannabinoids modulate human blood-brain barrier permeability in vitro
-
Cannabinoid Signaling and Neuroinflammatory Diseases: A Melting pot for the Regulation of Brain Immune Responses
-
A Cannabinoid Receptor 2 Agonist Prevents Thrombin-Induced Blood-Brain Barrier Damage via the Inhibition of Microglial Activation and Matrix Metalloproteinase Expression in Rats
-
The brain in bone and fuel metabolism
-
Cannabidiol protects an in vitro model of the blood brain barrier (BBB) from oxygen glucose deprivation via PPARγ and 5-HT1A
-
ABC transporters P-gp and Bcrp do not limit the brain uptake of the novel antipsychotic and anticonvulsant drug cannabidiol in mice
-
Endocannabinoids and Heterogeneity of Glial Cells in Brain Function
-
Endocannabinoids and Heterogeneity of Glial Cells in Brain Function
-
Cannabinoid receptor 2 modulates susceptibility to experimental cerebral malaria through a CCL17-dependent mechanism
-
Targeting Cannabinoid CB2 Receptors in the Central Nervous System. Medicinal Chemistry Approaches with Focus on Neurodegenerative Disorders
-
Blood metabolite markers of neocortical amyloid-β burden: discovery and enrichment using candidate proteins
-
CB2 receptor activation prevents glial-derived neurotoxic mediator production, BBB leakage and peripheral immune cell infiltration and rescues dopamine neurons in the MPTP model of Parkinsonâs disease
-
The molecular mechanism and effect of cannabinoid-2 receptor agonist on the bloodspinal cord barrier permeability induced by ischemia-reperfusion injury
-
ENDOCANNABINOID SYSTEM: A multi-facet therapeutic target
-
Cannabinoids and Neuro-Inflammation: Regulation of Brain Immune Response
-
Peripherally selective cannabinoid 1 receptor (CB1R) agonists for the treatment of neuropathic pain
BLOOD-PRESSURE/VASORELAXATION (80)
-
Inhibitor of fatty acid amide hydrolase normalizes cardiovascular function in hypertension without adverse metabolic effects
-
N-arachidonoyl glycine, an endogenous lipid that acts as a vasorelaxant via nitric oxide and large conductance calcium-activated potassium channels
-
Cannabinoid and GABA modulation of sympathetic nerve activity and blood pressure in the dorsal periaqueductal gray of the rat
-
Cannabidiol as an emergent therapeutic strategy for lessening the impact of inflammation on oxidative stress
-
Triphasic blood pressure responses to cannabinoids: do we understand the mechanism?
-
Increased Blood Pressure Following Abrupt Cessation of Daily Cannabis Use
-
Low-volume binary drug therapy for the treatment of hypovolemia
-
Medial prefrontal cortex endocannabinoid system modulates baroreflex activity through CB1 receptors
-
Tolerance to Effects of High-Dose Oral {Delta}9-Tetrahydrocannabinol and Plasma Cannabinoid Concentrations in Male Daily Cannabis Smokers
-
Serum contents of endocannabinoids are correlated with blood pressure in depressed women
-
Enhanced vasorelaxant effects of the endocannabinoid-like mediator, oleamide, in hypertension
-
Vascular metabolism of anandamide to arachidonic acid affects myogenic constriction in response to intraluminal pressure elevation
-
Circulating anandamide and blood pressure in patients with obstructive sleep apnea
-
Endothelium-dependent mechanisms of the vasodilatory effect of the endocannabinoid, anandamide, in the rat pulmonary artery
-
Cannabinoid receptor activation in the nucleus tractus solitaries produces baroreflex-like responses in the rat
-
Role of endocannabinoids and cannabinoid-1 receptors in cerebrocortical blood flow regulation
-
Endocannabinoid system as a potential mechanism for n-3 long-chain polyunsaturated fatty acid mediated cardiovascular protection
-
Effects of Acute Stress on Cardiac Endocannabinoids, Lipogenesis, and Inflammation in Rats
-
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
-
Mechanisms of vasorelaxation induced by oleoylethanolamide in the rat small mesenteric artery
-
Modulation by 17β-estradiol of anandamide vasorelaxation in normotensive and hypertensive rats: a role for TRPV1 but not fatty acid amide hydrolase
-
Mechanism of Central Atypical Cannabinoid Receptor GPR18-Mediated Hypotension in Conscious Rats
-
Preventive and treatment effects of a hemp seed (Cannabis sativa L.) meal protein hydrolysate against high blood pressure in spontaneously hypertensive rats
-
Impaired hypotensive responses induced by intrathecally injected drugs in fructose-fed rats
-
The Novel Endocannabinoid Receptor GPR18 is Expressed in the Rostral Ventrolateral Medulla and Exerts Tonic Restraining Influence on Blood Pressure
-
Mechanisms of endothelium-dependent relaxation evoked by anandamide in isolated human pulmonary arteries
-
Vascular targets for cannabinoids: animal and human studies.
-
A new face of endocannabinoids in pharmacotherapy. Part I: Protective role of endocannabinoids in hypertension and myocardial infarction
-
A new face of endocannabinoids in pharmacotherapy. Part II. Role of endocannabinoids in inflammation-derived cardiovascular diseases
-
Cardiorespiratory Anomalies in Mice Lacking CB1 Cannabinoid Receptors
-
A novel hemp seed meal protein hydrolysate reduces oxidative stress factors in spontaneously hypertensive rats
-
The effects of obesity, diabetes and metabolic syndrome on the hydrolytic enzymes of the endocannabinoid system in animal and human adipocytes
-
Neuronal Nitric Oxide Synthase Dependent Elevation in Adiponectin in the Rostral Ventrolateral Medulla Underlies GPR18-mediated Hypotension in Conscious Rats
-
Cannabinoid receptor type 1 activation by arachidonylcyclopropylamide in rat aortic rings causes vasorelaxation involving calcium-activated potassium channel subunit alpha-1 and calcium channel, voltage-dependent, L type, alpha 1C subunit
-
Role of endocannabinoid 2-arachidonoylglycerol in the physiology and pathophysiology of the cardiovascular system
-
The hypotensive effect of intrathecally injected (m)VD-hemopressin(α) in urethane anesthetized rats
-
The Endocannabinoid Anandamide Mediates Hypoxic Pulmonary Vasoconstriction And Pulmonary Hypertension
-
Structural and functional characterization of hemp seed (Cannabis sativa L.) proteinderived antioxidant and antihypertensive peptides
-
METABOLIC EFFECTS OF MARIJUANA USE AMONG BLACKS.
-
Fatty Acid-Binding Protein 4 (FABP4): Pathophysiological Insights and Potent Clinical Biomarker of Metabolic and Cardiovascular Diseases.
-
Renal effects of chronic pharmacological manipulation of CB2 receptors in rats with dietinduced obesity
-
Chronic Adolescent Marijuana Use as a Risk Factor for Physical and Mental Health Problems in Young Adult Men.
-
What do we understand from clinical and mechanistic studies on acupuncture treatment for hypertension?
-
Pharmacological profiling of the hemodynamic effects of cannabinoid ligands: a combined in vitro and in vivo approach.
-
Cannabidiol causes endothelium-dependent vasorelaxation of human mesenteric arteries via CB1 activation.
-
Bi-directional CB1 receptor-mediated cardiovascular effects of cannabinoids in anaesthetized rats: role of the paraventricular nucleus.
-
Effects of high-fructose diets on central appetite signaling and cognitive function.
-
Endocannabinoid-mediated modulation of Gq/11 protein-coupled receptor signaling induced vasoconstriction and hypertension
-
Alterations in the Medullary Endocannabinoid System contribute to age related impairment of Baroreflex Sensitivity
-
Angiotensin II receptor blockers decrease serum concentration of fatty acid-binding protein 4 in patients with hypertension
-
Enhanced function of inhibitory presynaptic cannabinoid CB1 receptors on sympathetic nerves of DOCA-salt hypertensive rats
-
Enhanced vasorelaxation effect of endogenous anandamide on thoracic aorta in renal vascular hypertension rats
-
Mechanisms of vasorelaxation induced by the cannabidiol analogue compound O-1602 in the rat small mesenteric artery
-
Endocannabinoids and the Cardiovascular System in Health and Disease
-
Cannabinoid 2 receptoractivation reduces leukocyte adhesion and improves capillary perfusionin the iridial microvasculature during systemic inflammation
-
Cannabinoids-Induced Vasodilation in Rat Mesenteric Artery: Possible Mechanisms of Action
-
Central GPR109A Activation Mediates Glutamate-Dependent Pressor Response in Conscious Rats
-
Endovanilloids are potential activators of the trigeminovascular nocisensor complex
-
Age-specific influences of chronic administration of the fatty acid amide hydrolase inhibitor URB597 on cardiovascular parameters and organ hypertrophy in DOCA-salt hypertensive rats
-
Metabolic Syndrome Among Marijuana Users in the United States: An Analysis of National Health and Nutrition Examination Survey Data
-
Medullary Endocannabinoids Contribute to the Differential Resting Baroreflex Sensitivity in Rats with Altered Brain Renin-Angiotensin System Expression.
-
Vascular Dysfunction in a Transgenic Model of Alzheimerâs Disease: Effects of CB1R and CB2R Cannabinoid Agonists.
-
The endocannabinoid anandamide causes endothelium-dependent vasorelaxation in human mesenteric arteries.
-
Components of the cannabinoid system in the dorsal periaqueductal gray are related to resting heart rate
-
CB1 receptor activation in the rat paraventricular nucleus induces bi-directional cardiovascular effects via modification of glutamatergic and GABAergic neurotransmission
-
Pre-hospital identification and post-recovery challenges of intoxication with synthetic cannabinoid containing legal high products such as âExodus Damnationâ
-
Effects of activation of endocannabinoid system on myocardial metabolism. (click âICIâ for
-
Abrupt Quitting of Long-term Heavy Recreational Cannabis Use is Not Followed by Significant Changes in Blood Pressure and Heart Rate
-
Adverse effects after the use of JWH-210 â a case series from the EU Spice II plus project
-
Endocannabinoids in Cerebrovascular Regulation
-
Protective role of cannabinoid CB1 receptors and vascular effects of chronic administration of FAAH inhibitor URB597 in DOCA-salt hypertensive rats
-
Anandamide and its metabolites: what are their roles in the kidney?
-
Crosstalk between liver antioxidant and the endocannabinoid systems after chronic administration of the FAAH inhibitor, URB597, to hypertensive rats.
-
Marijuana Use and Its Effects in Pregnancy.
-
Magnitude and duration of cue-induced craving for marijuana in volunteers with cannabis use disorder.
-
Heterologous Regulation of the Cannabinoid Type 1 Receptor by Angiotensin II in Astrocytes of Spontaneously Hypertensive Rats
-
The Effect of Chronic Activation of the Novel Endocannabinoid Receptor GPR18 on Myocardial Function and Blood Pressure in Conscious Rats
-
Hemopressin peptides as modulators of the endocannabinoid system and their potential applications as therapeutic tools
-
Overactivation of cannabinoid receptor type 1 in rostral ventrolateral medulla promotes cardiovascular responses in spontaneously hypertensive rats
-
The endogenous lipid N-arachidonoyl glycine is hypotensive and nitric oxide-cGMPdependent vasorelaxant
BLOOD/PLATELETS/PLASMA (61)
-
Dietary docosahexaenoic acid supplementation alters select physiological endocannabinoid-system metabolites in brain and plasma
-
The relationship between plasma levels of the endocannabinoid, anandamide, sex steroids, and gonadotrophins during the menstrual cycle
-
Anandamide extends platelets survival through CB(1)-dependent Akt signaling
-
Effect of Cannabis sativa on Hematological Indices in Rats and Men
-
Anandamide and its congeners inhibit human plasma butyrylcholinesterase. Possible new roles for these endocannabinoids?
-
The endocannabinoid system and its role in schizophrenia: a systematic review of the literature
-
Plasma concentrations of endocannabinoids and related primary Fatty Acid amides in patients with post-traumatic stress disorder
-
Differential Expression of Intracellular and Extracellular CB(2) Cannabinoid Receptor Protein by Human Peripheral Blood Leukocytes
-
A selective antagonist reveals a potential role of G protein-coupled receptor 55 in platelet and endothelial cell function
-
Reductions in circulating endocannabinoid levels in individuals with post-traumatic stress disorder following exposure to the world trade center attacks
-
Endocannabinoid and cannabinoid-like fatty acid amide levels correlate with pain-related symptoms in patients with IBS-D and IBS-C: a pilot study.
-
Cannabinoid Receptor Type 2, but not Type 1, is Up-Regulated in Peripheral Blood Mononuclear Cells of Children Affected by Autistic Disorders
-
Detection of the endocannabinoid metabolome in human plasma and breast milk
-
The 2-arachidonoylglycerol effect on myosin light chain phosphorylation in human platelets
-
Mechanism of platelet activation induced by endocannabinoids in blood and plasma
-
Critical issues in the analysis of endocannabinoids and related compounds in plasma: artifactual isomerization and ex-vivo enzymatic generation of 2-monoacylglycerols
-
Influence of dietary fat intake on the endocannabinoid system in lean and obese subjects
-
Endocannabinoids Control Platelet Activation and Limit Aggregate Formation under Flow
-
Association of polymorphisms in the endocannabinoid system genes with myocardial infarction and plasma cholesterol levels
-
2-Arachidonoylglycerol enhances platelet formation from human megakaryoblasts
-
2-Arachidonoylglycerol enhances platelet formation from human megakaryoblasts
-
Organophosphate agents induce plasma hypertriglyceridemia in mouse via single or dual inhibition of the endocannabinoid hydrolyzing enzyme(s)
-
Effect of 2-arachidonoylglycerol on myosin light chain phosphorylation and platelet activation: The role of phosphatidylinositol 3 kinase/AKT pathway
-
The differential characterization of GPR55 receptor in human peripheral blood reveals a distinctive expression in monocytes and NK cells and a proinflammatory role in these innate cells
-
THE EFFECT OF EPIDIOLEX (CANNABIDIOL) ON SERUM LEVELS OF CONCOMITANT ANTI-EPILEPTIC DRUGS IN CHILDREN AND YOUNG ADULTS WITH TREATMENT-RESISTANT EPILEPSY IN AN EXPANDED ACCESS PROGRAM
-
Fatty Acid Binding Proteins (FABPs) are Intracellular Carriers for Î9- Tetrahydrocannabinol (THC) and Cannabidiol (CBD)
-
Effects of pro-inflammatory cytokines on cannabinoid CB1 and CB2 receptors in immune cells
-
Expression Analysis of CB2-GFP BAC Transgenic Mice
-
Endocannabinoids and related lipids in blood plasma following touch massage: a randomised, crossover study
-
Influence of rimonabant treatment on peripheral blood mononuclear cells flow cytometry analysis and gene expression profiling
-
Role of the endocannabinoid system in the emotional manifestations of osteoarthritis pain
-
Transdermal cannabidiol reduces inflammation and pain-related behaviours in a rat model of arthritis
-
Food Liking Enhances the Plasma Response of 2-Arachidonoylglycerol and of Pancreatic Polypeptide upon Modified Sham Feeding in Humans
-
Downstream effects of endocannabinoid on blood cells: implications for health and disease
-
Regulation of cAMP Intracellular Levels in Human Platelets Stimulated by 2- Arachidonoylglycerol
-
Monoglyceride lipase deficiency modulates endocannabinoid signaling and improves plaque stability in ApoE-knockout mice
-
Inhibition of interleukin-1β-induced endothelial tissue factor expression by the synthetic cannabinoid WIN 55,212-2
-
Sleep restriction alters plasma endocannabinoids concentrations before but not after exercise in humans
-
Blood metabolite markers of neocortical amyloid-β burden: discovery and enrichment using candidate proteins
-
Pre-hospital identification and post-recovery challenges of intoxication with synthetic cannabinoid containing legal high products such as âExodus Damnationâ
-
Effects of Different Levels of Hemp Seed (Cannabis Sativa L.) and Dextran Oligosaccharide on Growth Performance and Antibody Titer Response of Broiler Chickens
-
Effects of activation of endocannabinoid system on myocardial metabolism. (click âICIâ for
-
Cannabinoids and haemostasis. (click âICIâ for
-
Abrupt Quitting of Long-term Heavy Recreational Cannabis Use is Not Followed by Significant Changes in Blood Pressure and Heart Rate
-
Reductions in circulating endocannabinoid 2-arachidonoylglycerol levels in healthy human subjects exposed to chronic stressors
-
Metabolomic-Driven Elucidation of Serum Disturbances Associated with Alzheimerâs Disease and Mild Cognitive Impairment
-
Anandamide and its metabolites: what are their roles in the kidney?
-
Differential effects of endogenous, phyto and synthetic cannabinoids on thrombogenesis and platelet activity
-
Reduced Noradrenergic Signaling in the Spleen Capsule in the Absence of CB1 and CB2 Cannabinoid Receptors
-
Characterization of peripheral cannabinoid receptor expression and clinical correlates in schizophrenia
-
Repeated Thrombosis After Synthetic Cannabinoid Use
-
Modulation of monocytes by bioactive lipid anandamide in multiple sclerosis involves distinct Toll-like receptors
-
Restricted vs. unrestricted wheel running in mice: Effects on brain, behavior and endocannabinoids
-
Peripheral Blood Mononuclear Cells Infiltration Downregulates Decidual FAAH Activity in an LPS-Induced Embryo Resorption Model
-
Plasma palmitoylethanolamide (PEA) as a potential biomarker for impaired coronary function
-
Cannabinoid receptors on peripheral leukocytes from patients with schizophrenia: Evidence for defective immunomodulatory mechanisms Â
-
Circulating levels of endocannabinoids respond acutely to voluntary exercise, are altered in mice selectively bred for high voluntary wheel running, and differ between the sexes
-
Endocannabinoids concentrations in plasma associated with feed efficiency and carcass composition of beef steers.
-
Plasma endocannabinoid behaviour in total knee and hip arthroplasty.
-
A preliminary study of endocannabinoid system regulation in psychosis: Distinct alterations of CNR1 promoter DNA methylation in patients with schizophrenia
-
Serum endocannabinoids and N-acyl ethanolamines and the influence of simulated solar UVR exposure in humans in vivo
BONE MARROW (7)
-
Endocannabinoids Are Expressed in Bone Marrow Stromal Niches and Play a Role in Interactions of Hematopoietic Stem and Progenitor Cells with the Bone Marrow Microenvironment
-
Inactivation of the cannabinoid receptor CB1 prevents leukocyte infiltration and experimental fibrosis
-
Cannabinoid Receptor 2 Deficiency in Haematopoietic cells Aggravates Early Atherosclerosis in LDL Receptor Deficient Mice
-
Regulation of hematopoietic stem cell trafficking and mobilization by the endocannabinoid system
-
Activation of cannabinoid receptor 2 enhances osteogenic differentiation of bone marrow derived mesenchymal stem cells
-
Myeloid-Specific Deletion of Diacylglycerol Lipase α Inhibits Atherogenesis in ApoEDeficient Mice
-
Developmental Role of Macrophage Cannabinoid-1 Receptor Signaling in Type-2 Diabetes
BORDERLINE PERSONALITY DISORDER (8)
-
The use of Cannnabidiol (CBD) and Meditation to reduce Binge Drinking, Anxiety and to improve Emotional Regulation in Long Term Behavior Therapy
-
Borderline personality traits and substance use: genetic factors underlie the association with smoking and ever use of cannabis, but not with high alcohol consumption
-
Identity disturbance and substance-dependence in patients with borderline personality disorder
-
Cannabis use and suicidal ideations in high-school students
-
Genetic variation in personality traits explains genetic overlap between borderline personality features and substance use disorders
-
A New Perspective on the Pathophysiology of Borderline Personality Disorder: A Model of the Role of Oxytocin
-
Association between schizotypal and borderline personality disorder traits, and cannabis use in young adults
-
Contribution of health motive to cannabis use among high-school students
BOWEL DISORDERS (160)
-
Achalasia, status post myotomy
-
Rectal spasms
-
The Cannabinoid 1 Receptor (CNR1) 1359 G/A Polymorphism Modulates Susceptibility to Ulcerative Colitis and the Phenotype in Crohnâs Disease
-
The endocannabinoid system links gut microbiota to adipogenesis
-
Endocannabinoid control of gastric sensorimotor function in man
-
Involvement of cannabinoid-1 and cannabinoid-2 receptors in septic ileus
-
Pharmacological effects of cannabinoids on the Caco-2 cell culture model of intestinal permeability
-
Small intestinal cannabinoid receptor changes following a single colonic insult with oil of mustard in mice.
-
European Patent Application EP2044935- A composition containing non-psychotropic cannabinoids for the treatment of inflammatory diseases
-
Cannabinoids and the gut: New developments and emerging concepts
-
Gut feelings about the endocannabinoid system
-
Treatment of Crohnâs disease with cannabis: an observational study
-
Cannabidiol Reduces Intestinal Inflammation through the Control of Neuroimmune Axis
-
Efficacy of a Chinese herbal proprietary medicine (Hemp Seed Pill) for functional constipation
-
Is lipid signaling through cannabinoid 2 receptors part of a protective system?
-
ENDOGENOUS CANNABINOID SYSTEM REGULATES INTESTINAL BARRIER FUNCTION IN VIVO THROUGH CANNABINOID TYPE 1 RECEPTOR ACTIVATION
-
Association of genetic variation in cannabinoid mechanisms and gastric motor functions and satiation in overweight and obesity
-
A novel CB receptor GPR55 and its ligands are involved in regulation of gut movement in rodents
-
US Patent 7884133 B2 Cannabidiol derivatives such as 3-(2,6-dihydroxy-4-pentylphenyl)-4-prop-1-en-2-ylcyclohexene-1-carboxylic acid, used as as analgesics, antiinflammatory and antidiarrheal agents
-
Alternative targets within the endocannabinoid system for future treatment of gastrointestinal diseases
-
Cannabinoids mediate opposing effects on inflammation-induced intestinal permeability
-
Increasing endogenous 2-arachidonoylglycerol levels counteracts colitis and related systemic inflammation
-
Cannabinoid actions at TRPV channels: effects on TRPV3 and TRPV4 and their potential relevance to gastrointestinal inflammation
-
The effects of cannabidiolic acid and cannabidiol on contractility of the gastrointestinal tract of Suncus murinus
-
Effects of Cannabinoid Agonists on Sheep Sphincter of Oddi in vitro
-
Medical cannabis: the opportunity versus the temptation
-
Cannabinoids mediate opposing effects on inflammation-induced intestinal permeability
-
Cannabinoid HU210 Protects Isolated Rat Stomach against Impairment Caused by Serum of Rats with Experimental Acute Pancreatitis.
-
The Gastrointestinal Pharmacology of Cannabinoids: Focus on Motility
-
The JNK inhibitor XG-102 protects against TNBS-induced colitis
-
The effects of fasting duration on gastric emptying in man, an exploration of the role of the endocannabinoid system and inter-individual responsiveness
-
Endocannabinoid modulation of jejunal afferent responses to LPS
-
Cannabinoid receptor 1 in the vagus nerve is dispensable for body weight homeostasis but required for normal gastrointestinal motility
-
Evidence for the Putative Cannabinoid Receptor (GPR55)-Mediated Inhibitory Effects on Intestinal Contractility in Mice
-
Inhibiting fatty acid amide hydrolase normalizes endotoxin-induced enhanced gastrointestinal motility in mice
-
Genetic Epidemiology and Pharmacogenetics in Irritable Bowel Syndrome
-
Inhibitory effect of cannabichromene, a major non-psychotropic cannabinoid extracted from Cannabis sativa, on inflammation-induced hypermotility in mice
-
Targeting the endocannabinoid system with cannabinoid receptor agonists: pharmacological strategies and therapeutic possibilities
-
Gut microbiota and the development of obesity
-
Effects of palmitoylethanolamide on intestinal injury and inflammation caused by ischemia-reperfusion in mice
-
Cannabinoid signalling regulates inflammation and energy balance: The importance of the brain-gut axis
-
The Cannabinoid Receptor type 2 Q63R variant increases the risk of celiac disease: Implication for a novel molecular biomarker and future therapeutic intervention
-
The endocannabinoid system in inflammatory bowel diseases: from pathophysiology to therapeutic opportunity
-
Agents that act luminally to treat diarrhoea and constipation
-
The Dual Effect of Cannabinoid Receptor-1 Deficiency on the Murine Postoperative Ileus
-
Altered expression of type-1 and type-2 cannabinoid receptors in celiac disease
-
Role of endogenous cannabinoid system in the gut
-
Effect of high fat-diet and obesity on gastrointestinal motility
-
Cannabis Finds Its Way into Treatment of Crohnâs Disease
-
Irritable Bowel Syndrome and Migraine: Bystanders or Partners?
-
Cannabinoid Receptor 1 Gene and Irritable Bowel Syndrome: Phenotype and Quantitative Traits
-
Endocannabinoid and Cannabinoid-Like Fatty Acid Amide Levels Correlate with Pain-Related Symptoms in Patients with IBS-D and IBS-C: A Pilot Study
-
Pro-resolution, protective and anti-nociceptive effects of a cannabis extract in the rat gastrointestinal tract
-
A role for O-1602 and G protein-coupled receptor GPR55 in the control of colonic motility in mice
-
Repeated Low Dose Administration of the Monoacylglycerol Lipase Inhibitor JZL184 Retains CB1 Receptor Mediated Antinociceptive and Gastroprotective Effects
-
A potential role for GPR55 in gastrointestinal functions
-
Cannabis Induces a Clinical Response in Patients with Crohnâs Disease: a Prospective Placebo-Controlled Study
-
Acute Î9-tetrahydrocannabinol blocks gastric hemorrhages induced by the nonsteroidal anti-inflammatory drug diclofenac sodium in mice
-
Marijuana use patterns among patients with inflammatory bowel disease
-
The cannabinoid-1 receptor inverse agonist taranabant reduces abdominal pain and increases intestinal transit in mice.
-
Industrial hemp decreases intestinal motility stronger than indian hemp in mice
-
Preventive and therapeutic oral administration of the pentacyclic triterpene α,β-amyrin ameliorates dextran sulfate sodium-induced colitis in mice: The relevance of cannabinoid system
-
Interrogating Therapeutic Manipulation of the Endocannabinoid System in Human Colon
-
Cannabinoid CB2 receptor activation attenuates cytokine-evoked mucosal damage in a human colonic explant model without changing epithelial permeability
-
3-Carboxamido-5-aryl-isoxazoles as new CB2 agonists for the treatment of colitis
-
Angiotensin II-induced activation of central AT1 receptors exerts endocannabinoidmediated gastroprotective effect in rats
-
Magnolol inhibits colonic motility through down-regulation of voltage-sensitive L-type Ca(2+) channels of colonic smooth muscle cells in rats
-
Interleukin 17A evoked mucosal damage is attenuated by cannabidiol and anandamide in a human colonic explant model
-
Inhibition of fatty acid amide hydrolase (FAAH) as a novel therapeutic strategy in the treatment of pain and inflammatory diseases in the gastrointestinal tract
-
Decreased Enteric Fatty Acid Amide Hydrolase Activity is Associated with Colonic Inertia in Slow Transit Constipation
-
Cannabinoid-induced autophagy regulates suppressor of cytokine signaling (SOCS)-3 in intestinal epithelium
-
(Mo1121) Cannabinoid Use Decreases ED Utilization in a Gastroenterology Clinic Population
-
(Mo1122) Prevalence and Characterization of Cannabinoid Use in Patients With Gastrointestinal Disorders
-
Modulation of Gut-Specific Mechanisms by Chronic Î9-THC Administration in Male Rhesus Macaques Infected with Simian Immunodeficiency Virus: A Systems Biology Analysis
-
Palmitoylethanolamide, a naturally-occurring lipid, is an orally effective intestinal anti-inflammatory agent
-
Cannabinoids Alleviate Experimentally Induced Intestinal Inflammation by Acting at Central and Peripheral Receptors
-
GPR18 is required for a normal CD8αα intestinal intraepithelial lymphocyte compartment
-
Chronic administration of Î9-tetrahydrocannabinol induces intestinal anti-inflammatory microRNA expression during acute SIV infection of rhesus macaques
-
Selective inhibition of FAAH produces antidiarrheal and antinociceptive effect mediated by endocannabinoids and cannabinoid-like fatty acid amides
-
Toward modulation of the endocannabinoid system for treatment of gastrointestinal disease: FAAHster but not âhigherâ
-
Ultramicronized palmitoylethanolamide normalizes intestinal motility in a murine model of post-inflammatory accelerated transit: involvement of CB1 receptors and TRPV1
-
Palmitoylethanolamide Regulates Development of Intestinal Radiation Injury in a Mast Cell-Dependent Manner
-
Medical Marijuana for Digestive Disorders: High Time to Prescribe?
-
Epigenetic Regulation of Genes that Modulate Chronic Stress-induced Visceral Pain in the Peripheral Nervous System
-
Acute Activation of Cannabinoid Receptors by Anandamide Reduces Gastro-Intestinal Motility and Improves Postprandial Glycemia in Mice
-
Antibiotic-induced dysbiosis alters host-bacterial interactions and leads to colonic sensory and motor changes in mice
-
N-Acylethanolamine-hydrolyzing acid amidase inhibition increases colon N palmitoylethanolamine levels and counteracts murine colitis
-
Association of cannabinoid type 1 receptor and fatty acid amide hydrolase genetic polymorphisms in Chinese patients with irritable bowel syndrome
-
Glucose metabolism: Focus on gut microbiota, the endocannabinoid system and beyond
-
Vagal anandamide signaling via cannabinoid receptor 1 contributes to luminal 5-HT modulation of visceral nociception in rats
-
The endocannabinoid anandamide regulates the peristaltic reflex by reducing neuroneuronal and neuro-muscular neurotransmission in ascending myenteric reflex pathways in rats
-
Potential therapeutic applications of cannabinoids in gastrointestinal and liver diseases: Focus on Î9-tetrahydrocannabinol pharmacology
-
Gut microbiota and obesity: Role in aetiology and potential therapeutic target
-
Colitis generates remote antinociception in rats: the role of the L arginine/NO/cGMP/PKG/KATP pathway and involvement of cannabinoid and opioid systems
-
Role of orphan G protein-coupled receptor 55 in diabetic gastroparesis in mice
-
Cannabis use provides symptom relief in patients with inflammatory bowel disease but is associated with worse disease prognosis in patients with Crohnâs disease
-
Monoglyceride lipase-deficiency causes desensitization of intestinal cannabinoid receptor type 1 and increased colonic μ-opioid receptor sensitivity
-
Increased Cerebral Cannabinoid-1 Receptor Availability Is a Stable Feature of Functional Dyspepsia: A [F]MK-9470 PET Study
-
No association between the functional cannabinoid receptor type 2 Q63R variants and inflammatory bowel disease in Turkish subjects
-
Gastric mucosal protection: from the periphery to the central nervous systemÂ
-
Adipose tissue NAPE-PLD controls fat mass development by altering the browning process and gut microbiota
-
The successful use of dronabinol for failure to thrive secondary to intestinal dysmotility
-
Pharmacogenetics in irritable bowel syndrome
-
Extraordinary cause of acute gastric dilatation and hepatic portal venous gas: Chronic use of synthetic cannabinoid
-
Prevention of Diet-Induced Obesity Effects on Body Weight and Gut Microbiota in Mice Treated Chronically with Î9-Tetrahydrocannabinol
-
Self-medication of achalasia with cannabis, complicated by a cannabis use disorder
-
A Gut Microbial Metabolite of Linoleic Acid, 10-Hydroxy-cis-12-octadecenoic Acid, Ameliorates Intestinal Epithelial Barrier Impairment Partially via GPR40-MEK-ERKÂ Pathway
-
A Gut Microbial Metabolite of Linoleic Acid, 10-Hydroxy-cis-12-octadecenoic Acid, Ameliorates Intestinal Epithelial Barrier Impairment Partially via GPR40-MEK-ERK Pathway
-
Multitarget fatty acid amide hydrolase/cyclooxygenase blockade suppresses intestinal inflammation and protects against nonsteroidal anti-inflammatory drug-dependent gastrointestinal damage
-
AM841, a covalent cannabinoid ligand, powerfully slows gastrointestinal motility in normal and stressed mice in a peripherally-restricted manner
-
Vascular, but not luminal, activation of FFAR1 (GPR40stimulates GLP-1 secretion from isolated perfused rat small intestine
-
Inhibiting endocannabinoid biosynthesis: a novel approach to the treatment of constipation
-
The GPR55 antagonist CID16020046 protects against intestinal inflammationÂ
-
In vitro and non-invasive in vivo effects of the cannabinoid-1 receptor agonist AM841 on gastrointestinal motor function in the rat
-
The effect of FAAH, MAGL, and Dual FAAH/MAGL inhibition on inflammatory and colorectal distension-induced visceral pain models in Rodents
-
The role of cannabinoids in regulation of nausea and vomiting, and visceral pain
-
Cannabinoids Regulate Intestinal Motor Function and Electrophysiological Activity of Myocytes in Rodents
-
Cannabis â therapy for the future?
-
Endocannabinoids and the Digestive Tract and Bladder in Health and Disease
-
The long-term functional consequences of acute infectious diarrhea
-
The Endocannabinoid System and Its Role in Regulating the Intrinsic Neural Circuitry of the Gastrointestinal Tract
-
Endocannabinoids â at the crossroads between the gut microbiota and host metabolism
-
Patterns of cannabis use in patients with Inflammatory Bowel Disease: A population based analysis
-
Vaccenic acid suppresses intestinal inflammation by increasing the endocannabinoid anandamide and non-cannabinoid signaling molecules in a rat model of the metabolic syndrome
-
Metabolism of Anandamide by Human Cytochrome P450 2J2 in the Reconstituted System and Human Intestinal Microsomes
-
Gastric acid inhibitory and gastric protective effects of Cannabis and cannabinoids
-
Cannabinoid hyperemesis syndrome as an unusual cause of cyclic vomiting
-
Unusual side effect of cannabis use: acute abdomen due to duodenal perforation
-
Abnormal cannabidiol attenuates experimental colitis in mice, promotes wound healing and inhibits neutrophil recruitment
-
Endocannabinoids in the Gut
-
Role of Gut Microbiota in the Aetiology of Obesity: Proposed Mechanisms and Review of the Literature
-
The CB2 receptor and its role as a regulator of inflammation
-
Anti-inflammatory effect of cannabinoid agonist WIN55, 212 on mouse experimental colitis is related to inhibition of p38MAPK
-
Longitudinal examination of the intestinal lamina propria cellular compartment of SIVinfected rhesus macaques provides broader and deeper insights into the link between aberrant microRNA expression and persistent immune activation
-
An Orally Active Cannabis Extract with High Content in Cannabidiol attenuates Chemically-induced Intestinal Inflammation and Hypermotility in the Mouse
-
Therapeutic Use of Cannabis in Inflammatory Bowel Disease
-
The Role of Visceral Hypersensitivity in Irritable Bowel Syndrome: Pharmacological Targets and Novel Treatments
-
Cannabis intake and intussusception: an accidental association?
-
Getting into the weed: the role of the endocannabinoid system in the brain-gut axis.
-
Efficacy, tolerability, and safety of cannabinoids in gastroenterology : A systematic review
-
RGS proteins as targets in the treatment of intestinal inflammation and visceral pain: New insights and future perspectives
-
Role of cannabinoids in gastrointestinal mucosal defense and inflammation
-
Central administrations of hemopressin and related peptides inhibit gastrointestinal motility in mice
-
MEDICAL CANNABIS
-
Endocannabinoids in the gut
-
The gastrointestinal tract â a central organ of cannabinoid signaling in health and disease
-
Cannabis and Pediatric Inflammatory Bowel Disease: Change Blossoms A Mile High
-
Determination of cannabinoids in hemp nuts products in Taiwan by HPLC-MS/MS coupled with chemometric analysis: Quality evaluation and a pilot human study
-
Oleoylethanolamine and palmitoylethanolamine modulate intestinal permeability in vitro via TRPV1 and PPARα
-
Docosahexaenoyl Serotonin, an endogenously formed n-3 fatty acid-serotonin conjugate has anti-inflammatory properties by attenuating IL-23âIL-17 signalling in macrophages
-
May cannabinoids prevent the development of chemotherapy-induced diarrhea and intestinal mucositis? Experimental study in the rat
-
Efficacy, tolerability, and safety of cannabinoids in gastroenterology: A systematic review
-
Cannabinoids and GI Disorders: Endogenous and Exogenous
-
Role of cannabis in digestive disordersÂ
-
Dietary Supplement Therapies for Inflammatory Bowel Disease: Crohnâs Disease and Ulcerative Colitis
-
Medical Cannabis â another piece in the mosaic of autoimmunity?
-
Application of carbon nanotubes as the carriers of the cannabinoid, 2- arachidonoylglycerol: Towards a novel treatment strategy in colitis
-
The Anti-Inflammatory Effect and Intestinal Barrier Protection of HU210 Differentially Depend on TLR4 Signaling in Dextran Sulfate Sodium-Induced Murine Colitis
-
Textual research on Han-Chinese formulae collected in Tubo medical manuscript unearthed in âBum-pa-Che Tower
-
Role of cannabis in digestive disorders
BRAIN (287)
-
Alterations in the hippocampal endocannabinoid system in diet-induced obese mice
-
Disposition of Cannabichromene, Cannabidiol, and Î9-Tetrahydrocannabinol and its Metabolites in Mouse Brain following Marijuana Inhalation Determined by High-Performance Liquid Chromatography-Tandem Mass Spectrometry
-
Quantification of brain endocannabinoid levels: methods, interpretations and pitfalls
-
Endocannabinoid signalling: has it got rhythm?
-
NSAIDs, Opioids, Cannabinoids and the Control of Pain by the Central Nervous System
-
The Role of Cannabinoid Receptors in the Descending Modulation of Pain
-
Cannabidiol reduces lipopolysaccharide-induced vascular changes and inflammation in the mouse brain: an intravital microscopy study
-
Fructose affects enzymes involved in the synthesis and degradation of hypothalamic endocannabinoids
-
Comparison of Cannabinoid CB1 Receptor Binding in Adolescent and Adult Rats: A Positron Emission Tomography Study Using [18F]MK-9470
-
N-Docosahhexanoyllethanolamide promotes development of hippocampal neurons
-
Alterations in Corticolimbic Dendritic Morphology and Emotional Behavior in Cannabinoid CB1 ReceptorâDeficient Mice Parallel the Effects of Chronic Stress
-
Effects of synthetic cannabinoids on electroencephalogram power spectra in rats
-
Marijuana Compound Improves Brain And Liver Function In Animal Model Of Hepatic Encephalopathy
-
Intermittent ethanol consumption depresses endocannabinoid-signaling in the dorsolateral striatum of rat
-
Temporal changes in N-acylethanolamine content and metabolism throughout the periadolescent period
-
Dopamine Response to Psychosocial Stress in Chronic Cannabis Users: A PET Study With [11C]-(+)-PHNO
-
Neural Circuit in the Dorsal Raphe Nucleus Responsible for Cannabinoid-Mediated Increases in 5-HT Efflux in the Nucleus Accumbens of the Rat Brain
-
The cannabinoid CB1 receptor biphasically modulates motor activity and regulates dopamine and glutamate release region dependently
-
Multiple functions of endocannabinoid signaling in the brain
-
CHRONIC, NONINVASIVE GLUCOCORTICOID ADMINISTRATION SUPPRESSES LIMBIC ENDOCANNABINOID SIGNALING IN MICE
-
Cannabinoid Receptor CB2 Modulates Axon Guidance
-
Mitochondrial CB(1) receptors regulate neuronal energy metabolism
-
The Endocannabinoid System and the Brain
-
The cannabinoid CB1 receptor biphasically modulates motor activity and regulates dopamine and glutamate release region dependently
-
Increased brain metabolism after acute administration of the synthetic cannabinoid HU210: a small animal PET imaging study with 18F-FDG
-
Manipulating brain connectivity with δ(9)-tetrahydrocannabinol: A pharmacological resting state FMRI study
-
Age of Stress Exposure Modulates the Immediate and Sustained Effects of Repeated Stress on
-
Impaired hippocampal glucoregulation in the cannabinoid CB(1) receptor knockout mice as revealed by an optimized in vitro experimental approach
-
A novel CB2 agonist, COR167, potently protects rat brain cortical slices against OGD and reperfusion injury
-
Role of endocannabinoids and cannabinoid-1 receptors in cerebrocortical blood flow regulation
-
A biophysical model of endocannabinoid-mediated short term depression in hippocampal inhibition
-
Cannabinoid- and lysophosphatidylinositol-sensitive receptor GPR55 boosts neurotransmitter release at central synapses
-
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
-
Brain Molecules and Appetite: The Case of Oleoylethanolamide (link to
-
Biosynthetic Pathways of Bioactive N-Acylethanolamines in Brain
-
Correspondence (letter to the editor): Cannabis Therapy
-
CB(2) receptor and amyloid pathology in frontal cortex of Alzheimerâs disease patients
-
Changes in cannabinoid CB1 receptor functionality in the female rat prefrontal cortex following a high fat diet
-
Imaging dopamine transmission parameters in cannabis dependence
-
Changes in cannabinoid CB1 receptor functionality in the female rat prefrontal cortex following a high fat diet
-
Cannabis affects people differently: inter-subject variation in the psychotogenic effects of Î9-tetrahydrocannabinol: a functional magnetic resonance imaging study with healthy volunteers
-
Therapeutic Utility of Cannabinoid Receptor Type 2 (CB2) Selective Agonists
-
Brain volume in male patients with recent onset schizophrenia with and without cannabis use disorders
-
Cocaine-Induced Behavioral Sensitization Is Associated With Changes in the Expression of Endocannabinoid and Glutamatergic Signaling Systems in the Mouse Prefrontal Cortex
-
Imaging dopamine transmission parameters in cannabis dependence
-
Species Differences in Cannabinoid Receptor 2 and Receptor Responses to Cocaine Self Administration in Mice and Rats
-
Programming and reprogramming neural cells by (endo-) cannabinoids: from physiological rules to emerging therapies
-
Modulation of early stress-induced neurobiological changes: a review of behavioural and pharmacological interventions in animal models
-
Expression and localization of cannabinoid receptor 1 in ratsâ brain treated with acute and repeated morphine
-
Rising stars: Modulation of brain functions by astroglial type-1 cannabinoid receptors
-
Endocannabinoid signalling and the deteriorating brain
-
Cannabidiol Rescues Acute Hepatic Toxicity and Seizure Induced by CocaineÂ
-
4â²-O-methylhonokiol increases levels of 2-arachidonoyl glycerol in mouse brain via selective inhibition of its COX-2-mediated oxygenation
-
Increased Cerebral Cannabinoid-1 Receptor Availability Is a Stable Feature of Functional Dyspepsia: A [F]MK-9470 PET Study
-
Role of dopamine type 1 receptors and DARPP-32 in Î9-THC-mediated induction of ÎFosB in the mouse forebrain
-
Homeostatic regulation of brain functions by endocannabinoid signaling
-
Metabolic Interplay between Astrocytes and Neurons Regulates Endocannabinoid Action.
-
Combined effects of marijuana and nicotine on memory performance and hippocampal volume
-
Daily marijuana use is not associated with brain morphometric measures in adolescents or adults
-
Fetal Alcohol Spectrum Disorder: Potential Role of Endocannabinoids Signaling
-
Evaluating the impact of cannabis use on thalamic connectivity in youth at clinical high risk of psychosis
-
Endocannabinoids Mediate Muscarinic Acetylcholine Receptor-Dependent Long-Term Depression in the Adult Medial Prefrontal Cortex
-
Cannabinoid receptor activation in the juvenile rat brain results in rapid biomechanical alterations: Neurovascular mechanism as a putative confounding factor
-
Impact of CB1 Receptor Deletion on Visual Responses and Organization of Primary Visual Cortex in Adult Mice
-
Neural correlates of cannabidiol and Î9-tetrahydrocannabinol interactions in mice: implications for medical cannabis
-
Cannabis, Cigarettes, and Their Co-Occurring Use: Disentangling Differences in Gray Matter Volume
-
Tetrahydrocannabivarin (THCv) reduces Default Mode Network and increases Executive Control Network Resting State Functional Connectivity in Healthy Volunteers
-
Brain transcriptome profiles in mouse model simulating features of post-traumatic stress disorder
-
Craving is associated with amygdala volumes in adolescent marijuana users during abstinence
-
The role of the Cannabinoid Receptor 1 in adolescentsâ processing of facial expressions
-
Developmental regulation of fear learning and anxiety behavior by endocannabinoids
-
Medical marijuana: review of the science and implications for developmental-behavioral pediatric practice
-
The basolateral amygdala γ-aminobutyric acidergic system in health and disease
-
Acute and Chronic Ethanol Exposure Differentially Regulate CB1 Receptor Function at Glutamatergic Synapses in the Rat Basolateral Amygdala
-
Enhanced Functional Activity of the Cannabinoid Type-1 Receptor Mediates Adolescent Behavior
-
Age-related changes in the endocannabinoid system in the mouse hippocampus
-
Protective effect of Xingnaojia formulation on rats with brain and liver damage caused by chronic alcoholism
-
Enhancement of endocannabinoid signalling protects against cocaine-induced neurotoxicity
-
Sex Differences in Molecular Signaling at Inhibitory Synapses in the Hippocampus
-
Training-Associated Emotional Arousal Shapes Endocannabinoid Modulation of Spatial Memory Retrieval in Rats
-
Rapid and profound rewiring of brain lipid signaling networks by acute diacylglycerol lipase inhibition
-
Mechanisms of stress in the brain
-
Shared Predisposition in the Association Between Cannabis Use and Subcortical Brain Structure
-
Neuronal expression of CB2 cannabinoid receptor mRNAs in the mouse hippocampus
-
A Hardwired Circuit Supplemented with Endocannabinoids Encodes Behavioral Choice in Zebrafish
-
The effects of beta-arrestin1 deletion on acute cannabinoid activity, brain cannabinoid receptors and tolerance to cannabinoids in mice
-
Possible inhibitory role of endogenous 2-arachidonoylglycerol as an endocannabinoid in (±)-epibatidine-induced activation of central adrenomedullary outflow in the rat
-
Thalamic and Cerebellar Gray Matter Volume Reduction in Synthetic Cannabinoids Users
-
Metabolome disruption of the rat cerebrum induced by the acute toxic effects of the synthetic cannabinoid MAM-2201
-
Combined neuroprotective action of adenosine A1 and cannabinoid CB1 receptors against NMDA-induced excitotoxicity in the hippocampus
-
Brain structural and clinical changes after first episode psychosis: Focus on cannabinoid receptor 1 polymorphisms
-
Changes over time of cannabinoid receptor 1 in hippocampus of status epilepticus ratsÂ
-
Strain and sex differences in puberty onset and the effects of THC administration on weight gain and brain volumes
-
Sex differences in associations between cannabis craving and neural responses to cannabis cues: Implications for treatment
-
Enhanced Glutamatergic Synaptic Plasticity in the Hippocampal CA1 Field of FoodRestricted Rats: Involvement of CB1 Receptors
-
The effect of WIN 55,212-2 suggests a cannabinoid-sensitive component in the early toxicity induced by organic acids accumulating in glutaric acidemia type I and in related disorders of propionate metabolism in rat brain synaptosomes
-
Reduced Brain Cannabinoid Receptor Availability In Schizophrenia
-
Neuroprotective Effect Is Driven Through the Upregulation of CB1 Receptor in Experimental Autoimmune Encephalomyelitis
-
Brain Mapping-Based Model of Î9-Tetrahydrocannabinol Effects on Connectivity in the Pain Matrix
-
The brain in bone and fuel metabolism
-
Î9-Tetrahydrocannabinol (Î9-THC) Promotes Neuroimmune-Modulatory MicroRNA Profile in Striatum of Simian Immunodeficiency Virus (SIV)-Infected Macaques
-
The Role of the Brainâs Endocannabinoid System in Pain and Its Modulation by Stress
-
Deletion of CB2 cannabinoid receptors reduces synaptic transmission and long-term potentiation in the mouse hippocampus
-
Dose-dependent teratogenicity of the synthetic cannabinoid CP-55,940 in mice
-
The effect of cannabis on oxidative stress and neurodegeneration induced by intrastriatal rotenone injection in rats
-
Intermittent access to liquid sucrose differentially modulates energy intake and related central pathways in control or high-fat fed mice
-
Functional interaction between the orexin-1 and CB1 receptors within the nucleus accumbens in the conditioned place preference induced by the lateral hypothalamus stimulation
-
Nicotine Changes Marijuanaâs Effect on the Brain
-
Expression and Function of the Endocannabinoid System in the Retina and the Visual Brain
-
Correlations between the Memory-Related Behavior and the Level of Oxidative Stress Biomarkers in the Mice Brain, Provoked by an Acute Administration of CB Receptor Ligands
-
CB2 Cannabinoid Receptor Knockout in Mice Impairs Contextual Long-Term Memory and Enhances Spatial Working Memory
-
GABABR-Dependent Long-Term Depression at Hippocampal Synapses between CB1- Positive Interneurons and CA1 Pyramidal Cells
-
GABA and Endocannabinoids Mediate Depotentiation of Schaffer Collateral Synapses Induced by Stimulation of Temperoammonic Inputs
-
A collaboration investigating endocannabinoid signalling in brain and bone
-
Cannabis for posttraumatic stress disorder: A neurobiological approach to treatment
-
Impaired Ethanol-Induced Sensitization and Decreased Cannabinoid Receptor-1 in a Model of Posttraumatic Stress Disorder
-
Endovanilloids are potential activators of the trigeminovascular nocisensor complex
-
Neuronal and Astrocytic Monoacylglycerol Lipase Limit the Spread of Endocannabinoid Signaling in the Cerebellum
-
Grey Matter Changes Associated with Heavy Cannabis Use: A Longitudinal sMRI Study
-
Cannabinoid receptor type-1: breaking the dogmas
-
p21-activated kinase 1 restricts tonic endocannabinoid signaling in the hippocampus
-
Endocannabinoid Modulation of Orbitostriatal Circuits Gates Habit Formation
-
Stimulation of brain glucose uptake by cannabinoid CB2 receptors and its therapeutic potential in Alzheimerâs disease
-
Amyloid proteotoxicity initiates an inflammatory response blocked by cannabinoids
-
Opposite regulation of cannabinoid CB1 and CB2 receptors in the prefrontal cortex of rats treated with cocaine during adolescence
-
URB597 inhibits oxidative stress induced by alcohol binging in the prefrontal cortex of adolescent rats
-
Case Series of Synthetic Cannabinoid Intoxication from One Toxicology Center
-
Synthetic cannabinoids revealing adrenoleukodystrophy
-
Does modulation of the endocannabinoid system have potential therapeutic utility in cerebellar ataxia?
-
Endocannabinoid control of glutamate NMDA receptors: the therapeutic potential and consequences of dysfunction
-
Medullary Endocannabinoids Contribute to the Differential Resting Baroreflex Sensitivity in Rats with Altered Brain Renin-Angiotensin System Expression
-
Association between cerebral cannabinoid 1 receptor availability and body mass index in patients with food intake disorders and healthy subjects: a [(18)F]MK-9470 â PET study
-
Acute upregulation of neuronal mitochondrial type-1 cannabinoid receptor and itâs role in metabolic defects and neuronal apoptosis after TBI
-
Cannabinoid receptor 2 modulates susceptibility to experimental cerebral malaria through a CCL17-dependent mechanism
-
Effects of Cannabidiol and Hypothermia on Short-Term Brain Damage in New-Born Piglets after Acute Hypoxia-Ischemia
-
Effect of Pharmacological Modulation of the Endocannabinoid System on Opiate Withdrawal: A Review of the Preclinical Animal Literature
-
Orexins contribute to restraint stress-induced cocaine relapse by endocannabinoidmediated disinhibition of dopaminergic neurons
-
Endocannabinoids and Heterogeneity of Glial Cells in Brain Function
-
Interaction between interleukin-1β and type-1 cannabinoid receptor is involved in anxiety-like behavior in experimental autoimmune encephalomyelitis
-
Endocannabinoid signaling in social functioning: an RDoC perspective
-
Targeting Cannabinoid CB2 Receptors in the Central Nervous System. Medicinal Chemistry Approaches with Focus on Neurodegenerative Disorders
-
Vascular Dysfunction in a Transgenic Model of Alzheimerâs Disease: Effects of CB1R and CB2R Cannabinoid Agonists
-
Blood metabolite markers of neocortical amyloid-β burden: discovery and enrichment using candidate proteins
-
Exposure to a Highly Caloric Palatable Diet during the Perinatal Period Affects the Expression of the Endogenous Cannabinoid System in the Brain, Liver and Adipose Tissue of Adult Rat Offspring
-
Adverse Social Experiences in Adolescent Rats Result in Enduring Effects on Social Competence, Pain Sensitivity and Endocannabinoid Signaling
-
Maternal Caloric Restriction Implemented during the Preconceptional and Pregnancy Period Alters Hypothalamic and Hippocampal Endocannabinoid Levels at Birth and Induces Overweight and Increased Adiposity at Adulthood in Male Rat Offspring
-
Biased Agonism of Three Different Cannabinoid Receptor Agonists in Mouse Brain Cortex
-
Endocannabinoid System: the Direct and Indirect Involvement in the Memory and Learning Processesâa Short Review
-
Regional Influence of Cannabinoid CB1 Receptors in the Regulation of Ethanol SelfAdministration by Wistar Rats
-
Individual differences in frontolimbic circuitry and anxiety emerge with adolescent changes in endocannabinoid signaling across species
-
Cannabinoids reverse the effects of early stress on neurocognitive performance in adulthood.
-
Ontogeny of sensorimotor gating and short-term memory processing throughout the adolescent period in rats
-
Modulation of Long-Term Potentiation of Cortico-Amygdala Synaptic Responses and Auditory Fear Memory by Dietary Polyunsaturated Fatty Acid
-
Components of the cannabinoid system in the dorsal periaqueductal gray are related to resting heart rate
-
CB1 receptor activation in the rat paraventricular nucleus induces bi-directional cardiovascular effects via modification of glutamatergic and GABAergic neurotransmission
-
Target-specific modulation of the descending prefrontal cortex inputs to the dorsal raphe nucleus by cannabinoids
-
Synthesis, Biodistribution and In vitro Evaluation of Brain Permeable High Affinity Type 2 Cannabinoid Receptor Agonists [11C]MA2 and [18F]MA3
-
Coordinated regulation of endocannabinoid-mediated retrograde synaptic suppression in the cerebellum by neuronal and astrocytic monoacylglycerol lipase
-
α/β-Hydrolase Domain 6 in the Ventromedial Hypothalamus Controls Energy Metabolism Flexibility
-
Neurophysiology of space travel: energetic solar particles cause cell type-specific plasticity of neurotransmission
-
Alteration of SLP2âlike immunolabeling in mitochondria signifies early cellular damage in developing and adult mouse brain
-
Hippocampal harms, protection and recovery following regular cannabis use
-
Cannabidiol attenuates OGD/R-induced damage by enhancing mitochondrial bioenergetics and modulating glucose metabolism via pentose-phosphate pathway in hippocampal neurons
-
Lifelong imbalanced linoleic/alpha-linolenic acid intake impairs emotional and cognitive behavior in adult rats via changes in brain endocannabinoid system (click âFull Text Linksâ to
-
Ovariectomy Alters Gene Expression of the Hippocampal Formation in Middle-Aged Rats
-
Î9-Tetrahydrocannabinol decreases willingness to exert cognitive effort in male rats
-
Anti-N-methyl-D-aspartate receptor encephalitis and drug abuse â the probable role of molecular mimicry or the overstimulation of CB receptors in a 17-year-old adolescent-case report (link to
-
Marijuana effects on changes in brain structure and cognitive function among HIV+ and HIV- adults
-
Cannabinoids in the Brain: New Vistas on an Old Dilemma
-
Harvesting Benefits from Cannabinoids
-
Suppressing Schizophrenia Symptoms Without Side Effects: Mouse Study
-
Treating Depression in Alcoholics
-
Acute Neurologic Disorder from an Inhibitor of Fatty Acid Amide Hydrolase
-
Lipids in psychiatric disorders and preventive medicine
-
Brain reactivity to alcohol and cannabis marketing during sobriety and intoxication
-
Protein purification and cloning of diacylglycerol lipase from rat brain
-
Dentate cannabinoid-sensitive interneurons undergo unique and selective strengthening of mutual synaptic inhibition in experimental epilepsy
-
Cocaine-induced behavioral sensitization decreases the expression of endocannabinoid signaling-related proteins in the mouse hippocampus
-
Endocannabinoids in Cerebrovascular Regulation
-
Interplay between serotonin and cannabinoid function in the amygdala in fear conditioning
-
Expression of functional cannabinoid CB2 receptor in VTA dopamine neurons in rats
-
Cannabidiol, neuroprotection and neuropsychiatric disorders
-
Immunohistochemical distribution of the cannabinoid receptor 1 and fatty acid amide hydrolase in the dog claustrum
-
Nutritional n-3 PUFA Deficiency Abolishes Endocannabinoid Gating of Hippocampal Long-Term Potentiation
-
Functional effects of cannabinoids during dopaminergic specification of human neural precursors derived from induced pluripotent stem cells
-
Brain 2-Arachidonoylglycerol Levels Are Dramatically and Rapidly Increased Under Acute Ischemia-Injury Which Is Prevented by Microwave Irradiation
-
Electrophysiological Measurement of Cannabinoid-Mediated Synaptic Modulation in Acute Mouse Brain Slices
-
Broad impact of deleting endogenous cannabinoid hydrolyzing enzymes and the CB1 cannabinoid receptor on the endogenous cannabinoid-related lipidome in eight regions of the mouse brain
-
Endocannabinoid 2-Arachidonoylglycerol Suppresses LPS-Induced Inhibition of A-Type Potassium Channel Currents in Caudate Nucleus Neurons Through CB1 Receptor
-
Interaction between paired-pulse facilitation and long-term potentiation during the stimulation of the cannabinoid and vanilloid systems in the dentate gyrus
-
Cannabidiol attenuates haloperidol-induced catalepsy and c-Fos protein expression in the dorsolateral striatum via 5-HT1A receptors in mice
-
Cannabinoid Type 2 Receptors Mediate a Cell Type-Specific Plasticity in the Hippocampus
-
Driving the need to feed: Insight into the collaborative interaction between ghrelin and endocannabinoid systems in modulating brain reward systems
-
Fabp-1 gene ablation impacts brain endocannabinoid system in male mice
-
Direct presynaptic and indirect astrocyte-mediated mechanisms both contribute to endocannabinoid signaling in the pedunculopontine nucleus of mice
-
Neural endocannabinoid CB1 receptor expression, social status, and behavior in male European starlings
-
Neural mechanisms of sensitivity to peer information in young adult cannabis users
-
Hierarchical glucocorticoid-endocannabinoid interplay regulates the activation of the nucleus accumbens by insulin.
-
Activity of muscarinic, galanin and cannabinoid receptors in the prodromal and advanced stages in the triple transgenic mice model of Alzheimerâs disease
-
Activation of endocannabinoid system in the rat basolateral amygdala improved scopolamine-induced memory consolidation impairment
-
Effect of synthetic cannabinoids on spontaneous neuronal activity: Evaluation using Ca2+ spiking and multi-electrode arrays
-
Experimental Evidence that 3-Methylglutaric Acid Disturbs Mitochondrial Function and Induced Oxidative Stress in Rat Brain Synaptosomes: New Converging Mechanisms
-
Activation of cannabinoid CB1 receptors in the ventral hippocampus improved stressinduced amnesia in rat
-
Ethanol downregulates N-acyl phosphatidylethanolamine-phospholipase D expression in BV2 microglial cells via epigenetic mechanisms
-
Autophagy activation by novel inducers prevents BECN2-mediated drug tolerance to cannabinoids
-
Basolateral amygdala CB1 cannabinoid receptors are involved in cross state-dependent memory retrieval between morphine and ethanol
-
Cannabinoids and Neuro-Inflammation: Regulation of Brain Immune Response
-
Fatty Acid Amide Hydrolase Binding in Brain of Cannabis Users: Imaging With the Novel Radiotracer [11C]CURB
-
Endocannabionoid System in Neurological Disorders
-
Just add water: cannabinoid discrimination in a water T-maze with FAAH(-/-) and (+/+) mice
-
Consequences of adolescent use of alcohol and other drugs: Studies using rodent models
-
Deficient adolescent social behavior following early-life inflammation is ameliorated by augmentation of anandamide signaling
-
Short-term effects of cannabidiol after global hypoxia-ischemia in newborn piglets
-
Cannabinoid receptor agonist WIN55,212-2 and fatty acid amide hydrolase inhibitor URB597 may protect against cognitive impairment in rats of chronic cerebral hypoperfusion via PI3K/AKT signaling
-
Female Mice are Resistant to Fabp1 Gene Ablation-Induced Alterations in Brain Endocannabinoid Levels
-
Adolescent cannabis use: What is the evidence for functional brain alteration?
-
Endocannabinoids control vesicle release mode at midbrain periaqueductal grey inhibitory synapses
-
The cannabinoid receptor agonist WIN55.212 reduces consequences of status epilepticus in rats
-
Peripheral and central CB1 cannabinoid receptors control stress-induced impairment of memory consolidation
-
Heterologous Regulation of the Cannabinoid Type 1 Receptor by Angiotensin II in Astrocytes of Spontaneously Hypertensive Rats
-
Anandamide reverses depressive-like behavior, neurochemical abnormalities and oxidative-stress parameters in streptozotocin-diabetic rats: Role of CB1 receptors
-
mGluR1/5 activation in the lateral hypothalamus increases food intake via the endocannabinoid system
-
Selective modulator of cannabinoid receptor type 2 reduces memory impairment and infarct size during cerebral hypoperfusion and vascular dementia
-
The neurobiology of social play and its rewarding value in rats
-
Sex differences in alcohol consumption and alterations in nucleus accumbens endocannabinoid mRNA in alcohol-dependent rats
-
CB1 cannabinoid receptor-mediated anandamide signalling mechanisms of the inferior colliculus modulate the haloperidol-induced catalepsy
-
Selective modulator of cannabinoid receptor type 2 (CB2) against biochemical alterations and brain damage in chronic cerebral hypoperfusion induced vascular dementia
-
Abnormal white matter integrity in synthetic cannabinoid users
-
Important role of endocannabinoid signaling in the development of functional vision and locomotion in zebrafish
-
Sexually-dimorphic alterations in cannabinoid receptor density depend upon prenatal/early postnatal history
-
Seeing through the smoke: human and animal studies of cannabis use and endocannabinoid signalling in corticolimbic networks
-
Decreased CB receptor binding and cannabinoid signaling in three brain regions of a rat model of schizophrenia
-
N-palmitoylethanolamide in the anterior cingulate cortex attenuates inflammatory pain behaviour indirectly via a CB1 receptor-mediated mechanism
-
Cannabinoids: Glutamatergic Transmission and Kynurenines
-
Expression of Dopamine Receptor 1A and Cannabinoid Receptor 1 Genes in the Cochlea and Brain after Salicylate-Induced Tinnitus
-
Interactive effects of AM251 and baclofen on synaptic plasticity in the rat dentate gyrus
-
Restricted vs. unrestricted wheel running in mice: Effects on brain, behavior and endocannabinoids
-
Interaction between hippocampal serotonin and cannabinoid systems in reactivity to spatial and object novelty detection
-
Neuroprotective Effects of Cannabidiol In Hypoxic Ischemic Insult: The Therapeutic Window In Newborn Mice
-
Cannabinoid CB1 receptors in distinct circuits of the extended amygdala determine fear responsiveness to unpredictable threat
-
Drug-Induced Alterations of Endocannabinoid-Mediated Plasticity in Brain Reward Regions
-
Dysregulation of the endocannabinoid signaling system in the cerebellum and brainstem in a transgenic mouse model of spinocerebellar ataxia type-3.
-
Nature of the placebo and nocebo effect in relation to functional neurologic disorders
-
Chronic stress leads to epigenetic dysregulation of neuropeptide-Y and cannabinoid CB1 receptor in the mouse cingulate cortex
-
Chronic FAAH inhibition during nicotine abstinence alters habenular CB1 receptor activity and precipitates depressive-like behaviors
-
Endocannabinoids and sleep
-
Cannabinoids prevent the amyloid β-induced activation of astroglial hemichannels: A neuroprotective mechanism
-
Effects of Marijuana on ictal and interictal EEG activity in idiopathic generalized epilepsy
-
Cannabinoid Receptor 2 Activation Restricts Fibrosis and Alleviates Hydrocephalus after Intraventricular Hemorrhage
-
Decreased CB receptor binding and cannabinoid signaling in three brain regions of a rat model of schizophrenia
-
Cortical and spinal excitability in patients with multiple sclerosis and spasticity after oromucosal cannabinoid spray
-
CB1 cannabinoid receptor-mediated anandamide signalling reduces the defensive behaviour evoked through GABAA receptor blockade in the dorsomedial division of the ventromedial hypothalamus
-
Differential Adulthood Onset mGlu5 Signaling Saves Prefrontal Function in the Fragile X Mouse
-
Pros and cons of medical cannabis use by people with chronic brain disorders
-
Cannabinoid Modulation of Memory Consolidation within the Cerebellum